Description
Erdanat 3 Tablet is an anticancer medication containing the active constituent erdafitinib. It is used to treat a type of cancer known as locally advanced or metastatic urothelial carcinoma, which mainly affects the bladder and urinary tract. This medicine is generally prescribed for patients whose cancer has specific genetic changes in fibroblast growth factor receptor (FGFR) genes and who have already received prior chemotherapy.
Erdanat 3 Tablet is a targeted therapy that helps slow down or stop the growth of cancer cells by blocking certain proteins involved in tumour development. It is taken orally and requires close monitoring, especially for eye-related side effects and changes in blood phosphate levels. Erdanat Tablet substitutes includes which contains erdafitinib.
Reviews
There are no reviews yet.